KarXT is a safe and effective novel antipsychotic for patients with schizophrenia
1. Patients in the KarXT (xanomeline–trospium) group reported a significant reduction in Positive and Negative Syndrome Scale (PANSS) score compared ...
Tag: Psychosis
Early non-response is a predictor of later non-response to antipsychotics in schizophrenia
1. For patients with schizophrenia, symptomatic response to antipsychotic medication at 2 and 4 weeks after initiation can appropriately predict ...
Emraclidine is safe and well-tolerated for the treatment of schizophrenia
1. Incidence of total adverse events and specific adverse events were similar between the emraclidine groups and placebo. 2. There ...
Wellness Check: Spirituality
Religion and spirituality dimensions may be beneficial in bipolar disorder symptoms 1. In this scoping review, intrinsic religiosity and positive ...
Majority of long-acting injectable and oral antipsychotics are similar in efficacy for schizophrenia maintenance therapy
1. There was no evidence of superiority among the different antipsychotics. 2. Choice of antipsychotic regimen for schizophrenia maintenance should ...
Vitamin D supplementation does not improve mental outcomes in adults with early psychosis
1. In this study, vitamin D supplementation in patients with first-episode psychosis did not lead to improved psychotic symptoms. 2. ...
Wellness Check: Nutrition
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
Vitamin D supplementation not supported to treat first-episode psychosis
1. The DFEND double-blind, randomized controlled trial revealed that Vitamin D supplementation led to no improvements in clinical outcomes at ...
Pimavanserin continuation lower psychosis relapse risk in patient with dementia-related psychosis
1. Pimavanserin was shown to lead to a lower risk of relapse of psychosis in patients who had an initial ...
Xanomeline-trospium treatment showed improvement in patients with schizophrenia
1. Xanomeline-trospium treatment showed a greater reduction in the degree of psychosis in patients with schizophrenia compared to placebo. 2. ...